Interim report
Page 1
PRESS RELEASE Lure July 29th , 2021 vetoquinol ACHIEVE MORE TOGETHER * 2021 FIRST HALF RESULTS STRONG PERFORMANCE ACROSS THE BOARD First half sales : € 255m ( up 33.5 % at constant exchange rates ) Essentials sales : € 143m ( up 45.2 % at constant exchange rates ) EBIT before depreciation of acquired assets : € 57m ( 22.3 % of sales ) Net income - Group share : € 36m Vetoquinol CEO Matthieu Frechin said : " The strong performance recorded in the first half of 2021 is a direct result of the major transformation program undertaken as part of our two most recent strategic plans . Our company has changed significantly as a result . Our portfolio now includes more high value- added products , Essentials products , and has been diversified to reduce our reliance on anti - infectives , without sacrificing our proven expertise in this strategic segment . This development dynamic gives us confidence in the coming months , and we expect to see double - digit growth in sales and EBIT in 2021. " FOR MORE INFORMATION , CONTACT : VETOQUINOL Investor Relations Fanny Toillon Tel .: +33 ( 0 ) 3 84 62 59 88 relations.investisseurs@vetoquinol.co m KEIMA COMMUNICATION Investor & Media Relations Emmanuel Dovergne Tel .: +33 ( 0 ) 1 56 43 44 63 emmanuel.dovergne@keima.fr At its meeting on July 28th , 2021 , the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the first half 2021 financial statements . A limited review has been completed and the relevant report has been issued by the Auditors . In a buoyant animal health world market that grew by around 5 % in the first half of 2021 ( company estimates ) , Vetoquinol posted sales of € 255 million , up 30.2 % as reported and up 33.5 % at constant exchange rates . Strong business growth in the first half was the result of strong momentum in Essentials products , up by € 45 million at constant exchange rates in H1 2021 , thanks to the successful integration of the DrontalⓇ and Profender® product range acquired on August 1st , 2020 and organic growth of 13.4 % . The company also recorded an increase in Complementary products , with organic growth of 21.5 % in the first half of 2021. Essentials products accounted for 55.9 % of Group sales in the first half of 2021 , up from 50.6 % for the same period in 2020 . Sales of pet products totaled € 167 million , representing 65 % of Vetoquinol sales and organic growth of 22 % . Sales of livestock products came to € 88 million , representing organic growth of 12 % . All strategic territories posted growth in H1 2021 at constant exchange rates : 38.3 % in Europe , 33.6 % in the Americas and 20.0 % in Asia / Pacific . VETOQUINOL Magny - Vernois 70200 Lure - France www.vetoquinol.com 1/5